The estimated Net Worth of Sharon Kochan is at least $3.57 millió dollars as of 5 March 2021. Mr. Kochan owns over 4,057 units of Perrigo plc stock worth over $1,035,734 and over the last 11 years he sold PRGO stock worth over $498,485. In addition, he makes $2,040,370 as Executive Vice President és President - RX Pharmaceuticals at Perrigo plc.
Sharon has made over 15 trades of the Perrigo plc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 4,057 units of PRGO stock worth $166,499 on 5 March 2021.
The largest trade he's ever made was exercising 7,304 units of Perrigo plc stock on 8 October 2019 worth over $379,370. On average, Sharon trades about 1,253 units every 92 days since 2013. As of 5 March 2021 he still owns at least 38,748 units of Perrigo plc stock.
You can see the complete history of Mr. Kochan stock trades at the bottom of the page.
Sharon Kochan serves as Executive Vice President, President - RX Pharmaceuticals of the Company. He served as Executive Vice President and President, Branded Consumer Healthcare International from February 2017 to October 2018. He served as Executive Vice President and General Manager, Consumer Healthcare International from August 2012 to February 2017. He served as Executive Vice President, General Manager of Prescription Pharmaceuticals from March 2007 to July 2012 and as Senior Vice President of Business Development and Strategy from March 2005 to March 2007. Mr. Kochan was Vice President, Business Development of Agis Industries (1983) Ltd. from July 2001 until the acquisition of Agis by the Company in March 2005.
As the Executive Vice President és President - RX Pharmaceuticals of Perrigo plc, the total compensation of Sharon Kochan at Perrigo plc is $2,040,370. There are 6 executives at Perrigo plc getting paid more, with Murray Kessler having the highest compensation of $10,807,800.
Sharon Kochan is 51, he's been the Executive Vice President és President - RX Pharmaceuticals of Perrigo plc since 2018. There are 24 older and 2 younger executives at Perrigo plc. The oldest executive at Perrigo Company plc is Rolf Classon, 75, who is the Independent Director.
Sharon's mailing address filed with the SEC is C/O PERRIGO COMPANY, 515 EASTERN AVENUE, ALLEGAN, MI, 49010.
Over the last 11 years, insiders at Perrigo plc have traded over $21,020,805 worth of Perrigo plc stock and bought 592,512 units worth $38,708,035 . The most active insiders traders include Jeffrey C Smith, Gary M Cohen és Joseph C Papa. On average, Perrigo plc executives and independent directors trade stock every 11 days with the average trade being worth of $156,424. The most recent stock trade was executed by Ronald Craig Janish on 26 August 2024, trading 13,000 units of PRGO stock currently worth $382,200.
perrigo company plc, a top five global over-the-counter (otc) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. from its beginnings in 1887 as a packager of generic home remedies, perrigo, headquartered in ireland, has grown to become the world's largest manufacturer of otc products and supplier of infant formulas for the store brand market. the company is also a leading provider of branded otc products, generic extended topical prescription products and receives royalties from multiple sclerosis drug tysabri®. perrigo provides “quality affordable healthcare products®” across a wide variety of product categories and geographies primarily in north america, europe, and australia, as well as other key markets including israel and china. visit perrigo online at (http://www.perrigo.com).
Perrigo plc executives and other stock owners filed with the SEC include: